QA: BIOXYTRAN INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001445815_2021_BIOXYTRAN_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001445815')"}

Graph

Absolute values for 0001445815, BIOXYTRAN INC

  xvar xval
0 AssetsCurrent 316,403
1 IntangibleAssetsNetIncludingGoodwill 10,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 2,267,659
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 476,315
9 ResearchAndDevelopmentExpense 544,519
10 remainder_Expenses 247,867
11 remainder_Revenues 0
12 remainder_NetIncome -1,211,917
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 326,403
1 Liabilities 2,267,659
2 Expenses 1,268,701
3 Revenues 0
4 StockholdersEquity -1,941,256
5 NetIncome -2,480,618
6 ComprehensiveNetIncome -2,480,618
7 BaseVar 2,537,340
8 EconomicCapitalRatio -4.49

Edgar->Model Mapping

Feature Distribution

Change over Time